Over 60 million people worldwide are diagnosed with glaucomatous optic neuropathy,
which is estimated to be responsible for 8.4 million cases of irreversible blindness globally …

Papilledema, defined as swelling of the optic disc, frequently occurs in the setting of
increased ICP and in a variety of medical conditions, including pseudotumor cerebri, sinus …

Nanoscale materials have been explored extensively as agents for therapeutic and
diagnostic (ie, theranostic) applications. Research efforts have shifted from exploring new …

Many ophthalmologists and members of the lay public alike view glaucoma in its historical
context—that is, as exclusively a disease of the eye. This view has been (and remains) …

NAP (davunetide) is a novel neuroprotective compound with mechanism of action that
appears to involve microtubule (MT) stabilization and repair. To evaluate, for the first time …

Glaucoma is a neurodegenerative disease that causes progressive, irreversible vision loss.
Currently, intraocular pressure (IOP) is the only modifiable risk factor for glaucoma …

Manganese-enhanced magnetic resonance imaging (MEMRI) rose to prominence in the
1990s as a sensitive approach to high contrast imaging. Following the discovery of …

Lycium Barbarum Polysaccharides (LBP) are the active components of Wolfberry (a
traditional Chinese medicine) which has long been used for improving visual function. This …

Although elevated intraocular pressure (IOP) and age are major risk factors for glaucoma,
their effects on glaucoma pathogenesis remain unclear. This study examined the onset and …

The retina, as part of the central nervous system is an ideal model to study the response of
neurons to injury and disease and to test new treatments. During the last decade is …